We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.32B
AUM Growth
+$155M
Cap. Flow
-$100M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.3%
Holding
739
New
50
Increased
312
Reduced
249
Closed
35

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$31M
2
CL icon
Colgate-Palmolive
CL
+$20M
3
MRK icon
Merck
MRK
+$18.8M
4
GLW icon
Corning
GLW
+$18.5M
5
FFIV icon
F5
FFIV
+$17.2M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$40.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38M
3
META icon
Meta Platforms (Facebook)
META
+$23.2M
4
ORCL icon
Oracle
ORCL
+$20.4M
5
MJN
Mead Johnson Nutrition Company
MJN
+$20.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.58%
2 Technology 13.62%
3 Financials 13.2%
4 Consumer Discretionary 9.51%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CA
476
DELISTED
CA, Inc.
CA
$1.68M 0.03%
48,687
+24,969
+105% +$808K
RNTX
477
Rein Therapeutics
RNTX
$67.7M
$1.67M 0.03%
+7,500
New +$1.65M
SWX icon
478
Southwest Gas
SWX
$6.74B
$1.66M 0.03%
+22,646
New +$1.81M
LUMN icon
479
Lumen
LUMN
$6.53B
$1.65M 0.03%
68,980
-74,125
-52% -$1.86M
GGP
480
DELISTED
GGP Inc.
GGP
$1.64M 0.03%
69,654
-95,229
-58% -$2.19M
MAN icon
481
ManpowerGroup
MAN
$2.39B
$1.63M 0.03%
14,598
-41,574
-74% -$4.29M
OMER icon
482
Omeros
OMER
$709M
$1.62M 0.03%
81,370
-27,000
-25% -$471K
ONCE
483
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.61M 0.03%
27,000
– –
FRC
484
DELISTED
First Republic Bank
FRC
$1.61M 0.03%
16,078
+2,812
+21% +$266K
BXP icon
485
Boston Properties
BXP
$11B
$1.59M 0.03%
12,942
+1,170
+10% +$148K
NOMD icon
486
Nomad Foods
NOMD
$1.64B
$1.57M 0.03%
111,250
– –
NOV icon
487
NOV
NOV
$7.45B
$1.56M 0.03%
47,234
– –
IFF icon
488
International Flavors & Fragrances
IFF
$19.4B
$1.55M 0.03%
11,508
+1,545
+16% +$209K
CPRX
489
DELISTED
Catalyst Pharmaceutical
CPRX
$1.55M 0.03%
560,000
-40,000
-7% -$83.5K
AZO icon
490
AutoZone
AZO
$48.3B
$1.54M 0.03%
2,709
+703
+35% +$458K
VAR
491
DELISTED
Varian Medical Systems, Inc.
VAR
$1.53M 0.03%
14,866
+4,621
+45% +$445K
RARX
492
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$1.52M 0.03%
+81,000
New +$1.83M
CPT icon
493
Camden Property Trust
CPT
$11.3B
$1.51M 0.03%
+17,702
New +$1.48M
SYF icon
494
Synchrony
SYF
$23.7B
$1.51M 0.03%
50,785
-77,603
-60% -$2.3M
COL
495
DELISTED
Rockwell Collins
COL
$1.5M 0.03%
14,295
-930
-6% -$96.3K
BCR
496
DELISTED
CR Bard Inc.
BCR
$1.5M 0.03%
4,745
-517
-10% -$154K
HBAN icon
497
Huntington Bancshares
HBAN
$35.1B
$1.48M 0.03%
109,178
-11,900
-10% -$154K
LRCX icon
498
Lam Research
LRCX
$382B
$1.48M 0.03%
104,310
-7,410
-7% -$109K
ETR icon
499
Entergy
ETR
$54.1B
$1.47M 0.03%
38,232
+10,018
+36% +$388K
REG icon
500
Regency Centers
REG
$15B
$1.47M 0.03%
23,414
+185
+0.8% +$11.7K
18 19
20
21 22

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2017 Portfolio in Review

As of Q2 2017, Candriam SCA held 739 positions worth $5.32B, up 3% from $5.17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q2 2017 filing shows 50 new, 312 increased, 249 reduced and 35 closed positions. Its largest new stake was Raymond James Financial: 164,790 shares worth $8.81M. The largest sale was PepsiCo, an estimated $40.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2017 buy was Raymond James Financial: 164,790 shares worth $8.81M.
  • Candriam SCA added most to Kellanova in Q2 2017, an estimated $31M increase.
  • Candriam SCA's biggest Q2 2017 reduction was PepsiCo, cutting an estimated $40.4M.
  • Candriam SCA fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $20.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.32B portfolio in Q2 2017.
  • Candriam SCA opened 50 new positions and closed 35 in Q2 2017.
  • Candriam SCA's portfolio value rose 3% quarter-over-quarter to $5.32B.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.